Skip to content
10-Q

Quarterly Report

NEXIEN BIOPHARMA, INC.

0001493152-21-029479

← back to feed
Filed
Nov 22, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Nov 22, 2021 55.77M sh
Cash And Equivalents Q1 2022 · Sep 30, 2021 $3.69K
Cash And Equivalents Q1 2022 · Jun 30, 2021 $18.04K
Current Liabilities Q1 2022 · Sep 30, 2021 $47.43K
Current Liabilities Q1 2022 · Jun 30, 2021 $39.32K
Current Assets Q1 2022 · Sep 30, 2021 $7.44K
Current Assets Q1 2022 · Jun 30, 2021 $25.54K
Total Assets Q1 2022 · Sep 30, 2021 $7.44K
Total Assets Q1 2022 · Jun 30, 2021 $25.54K
Operating Income Q1 2022 · Sep 30, 2021 $10.43M
Operating Cash Flow Q1 2022 · Sep 30, 2020 −$15.58K
Stockholders Equity Q1 2022 · Sep 30, 2020 −$7.48K
Stockholders Equity Q1 2022 · Jun 30, 2020 −$6.37K
Net Income Q1 2022 · Sep 30, 2020 −$1.06M